Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: The Oxford Regional Prospective Study

Clinical Endocrinology

Volumn 62, Issue 2, 2005, Pages 137-144

  Amin, Rakesh ^a   Williams, Rachel M ^a   Frystyk, January ^d   Umpleby, Margot ^e   Matthews, David ^b   Orskov, Hans ^d   Dalton, R Neil ^c   Dunger, David B ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN C;

ADOLESCENT; ADULT; ADULTHOOD; AGE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOURIER TRANSFORMATION; GENDER; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN CLEARANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN SENSITIVITY; MALE; MICROALBUMINURIA; MULTIPLE REGRESSION; PATHOGENESIS; PERIODICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; RISK FACTOR;

ADOLESCENT; ADULT; ALBUMINURIA; CASE-CONTROL STUDIES; CREATININE; DIABETES MELLITUS, TYPE 1; FEMALE; FOURIER ANALYSIS; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 13444279144     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02185.x     Document Type: Article

References (44)

1. Edge, J.A., Dunger, D.B., Matthews, D.R., Gilbert, J.P. & Smith, C.P. (1990) Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. Journal of Clinical Endocrinology and Metabolism, 71, 1356-1362,
2. Hansen, A.P. & Johansen, K. (1970) Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics. Diabetologia, 6, 27-33.
3. Clayton, K.L., Holly, J.M., Carlsson, L.M., Jones, J., Cheetham, T.D., Taylor, A.M. & Dunger, D.B. (1994) Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus. Clinical Endocrinology, 41, 517-524.
4. Chin, E., Zhou, J. & Bondy, C.A. (1992) Renal growth hormone receptor gene expression: relationship to renal insulin-like growth factor system. Endocrinology, 131, 3061-3066.
5. Lundbaek, K., Christensen, N.J., Jensen, V.A., Johansen, K., Olsen, T.S., Hansen, A.P., Orskov, H. & Osterby, R. (1970) Diabetes, diabetic angiopathy, and growth hormone. Lancet, 2, 131-133.
6. Sharp, P.S., Fallon, T.J., Brazier, O.J., Sandler, L., Joplin, G.F. & Kohner, E.M. (1987) Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia, 30, 199-207.
7. Merimee, T.J., Zapf, J. & Froesch, E.R. (1983) Insulin-like growth factors. Studies in diabetics with and without retinopathy. New England Journal of Medicine, 309, 527-530.
8. Feldmann, B., Jehle, P.M., Mohan, S., Lang, G.E., Lang, G.K., Brueckel, J. & Boehm, B.O. (2000) Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins. Growth Hormone and IGF Research, 10, 53-59.
9. Janssen, J.A. & Lamberts, S.W. (2000) Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clinical Endocrinology, 52, 1-9.
10. Pal, B.R., Phillips, P.E., Matthews, D.R. & Dunger, D.B. (1992) Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 35, 542-549.
11. Edge, J.A., Harris, D.A., Phillips, P.E., Pal, B.R., Matthews, D.R. & Dunger, D.B. (1993) Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents. Diabetes Care, 16, 1011-1018.
12. Schultz, C.J., Konopelska-Bahu, T., Dalton, R.N., Carroll, T.A., Stratton, I., Gale, E.A., Neil, A. & Dunger, D.B. (1999) Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. The Oxford Regional Prospective Study Group. Diabetes Care, 22, 495-502.
13. Amiel, S.A., Sherwin, R.S., Simonson, D.C., Lauritano, A.A. & Tamborlane, W.V. (1986) Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. New England Journal of Medicine, 315, 215-219.
14. Amin, R., Schultz, C., Ong, K., Frystyk, J., Dalton, R.N., Perry, L., Orskov, H. & Dunger, D.B. (2003) Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects. The Oxford Regional Prospective Study. Diabetes Care, 26, 1456-1461.
15. Segev, Y., Landau, D., Marbach, M., Shehadeh, N., Flyvbjerg, A. & Phillip, M. (1997) Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I. Journal of the American Society of Nephrology, 8, 436-444.
16. Doi, T., Striker, L.J., Gibson, C.C., Agodoa, L.Y., Brinster, R.L. & Striker, G.E. (1990) Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. American Journal of Pathology, 137, 541-552.
17. Segev, Y., Landau, D., Rasch, R., Flyvbjerg, A. & Phillip, M. (1999) Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice. Journal of the American Society of Nephrology, 10, 2374-2381.
18. Cummings, E.A., Sochett, E.B., Dekker, M.G. & Lawson, M.L. (1998) Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes, 47, 1341-1346.
19. Shinada, M., Akdeniz, A., Panagiotopoulos, S., Jerums, G. & Bach, L.A. (2000) Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy. Journal of Clinical Endocrinology and Metabolism, 85, 1163-1169.
20. Taylor, R.W., Keil, D., Gold, E.J., Williams, S.M. & Goulding, A. (1998) Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. American Journal of Clinical Nutrition, 67, 44-49.
21. Shojaee-Moradie, F., Jackson, N.C., Jones, R.H., Mallet, A.I., Hovorka, R. & Umpleby, A.M. (1996) Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo. Journal of Mass Spectrometry, 31, 961-966.
22. Merriam, G.R. & Wachter, K.W. (1982) Algorithms for the study of episodic hormone secretion. American Journal of Physiology, 243, E310-E318.
23. Matthews, D. (1988) Time series analysis in endocrinology. Acta Paediatrica Scandinavica, 347, 55-62.
24. Acerini, C.L., Cheetham, T.D., Edge, J.A. & Dunger, D.B. (2000) Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age. Diabetologia, 43, 61-68.
25. Steele, R. (1959) The influence of glucose loading and injected insulin on hepatic glucose output. Annals of the New York Academy of Science, 82, 420-430.
26. Mari, A. (1992) Estimation of the rate of appearance in the non-steady state with a two-compartment model. American Journal of Physiology, 263, E400-E415.
27. Ferrannini, E., Barrett, E.J., Bevilacqua, S., Jacob, R., Walesky, M., Sherwin, R.S. & Defronzo, R.A. (1983) Effect of fatty acids on glucose production and utilization in man. Journal of Clinical Investigations, 72, 1737-1747.
28. Edge, J.A., Matthews, D.R. & Dunger, D.B. (1990) The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clinical Endocrinology, 33, 729-737.
29. Williams, R.M., Amin, R., Shojaee-Moradie, F., Umpleby, A.M., Acerini, C.L. & Dunger, D.B. (2003) The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with type 1 diabetes mellitus. Diabetologia, 46, 1203-1210.
30. Acerini, C.L., Harris, D.A., Matyka, K.A., Watts, A.P., Umpleby, A.M., Russell-Jones, D.L. & Dunger, D.B. (1998) Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus. Metabolism, 47, 1481-1489.
31. Simpson, H.L., Jackson, N., Croos, P., et al (2001) IGF-I has an independent effect on glucose metabolism in type 1 diabetes. Proceedings of the American Endocrinology Society Conference.
32. Boden, G. (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 46, 3-10.
33. Seta, K.A. & Roth, R.A. (1997) Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. Biochemistry and Biophysics Research Communications, 231, 167-171.
34. Flyvbjerg, A., Marshall, S.M., Frystyk, J., Hansen, K.W., Harris, A.G. & Orskov, H. (1992) Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Kidney International, 41, 805-812.
35. Flyvbjerg, A. (2000) Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia, 43, 1205-1223.
36. Burgos, R., Mateo, C., Canton, A., Hernandez, C., Mesa, J. & Simo, R. (2000) Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care, 23, 80-83.
37. Pfeiffer, A., Spranger, J., Meyer-Schwickerath, R. & Shatz, H. (1997) Growth factor alterations in advanced diabetic retinopathy: a possible role of blood-retina barrier breakdown. Diabetes, 46, S26-S30.
38. Frystyk, J., Bek, T., Flyvbjerg, A., Skjaerbaek, C. & Orskov, H. (2003) The relationship between the circulating IGF system and the presence of retinopathy in type 1 diabetic patients. Diabetes Medicine, 20, 269-276.
39. Andersen, A.R., Christiansen, J.S., Andersen, J.K., Kreiner, S. & Deckert, T. (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia, 25, 496-501.
40. Yokoyama, H., Uchigata, Y., Otani, T., Aoki, K., Maruyama, H., Hori, S., Matsuura, N. & Omori, Y. (1994) Development of proliferative retinopathy in Japanese patients with IDDM. Tokyo Women's Medical College Epidemiologic Study in Diabetes Research. Clinical Practice, 24, 113-119.
41. Adcock, C.J., Perry, L.A., Lindsell, D.R., Taylor, A.M., Holly, J.M., Jones, J. & Dunger, D.B. (1994) Menstrual irregularities are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain. Diabetes Medicine, 11, 465-470.
42. Ahmed, M.L., Connors, M.H., Drayer, N.M., Jones, J.S. & Dunger, D.B. (1998) Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age. Diabetes Care, 21, 831-835.
43. Huffman, R.P., Vicini, P., Sivitz, W.I. & Cobelli, C. (2000) Pubertal adolescent male-female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model. Pediatrics Research, 48, 384-388.
44. Reckelhoff, J.F. & Granger, J.P. (1999) Role of androgens in mediating hypertension and renal injury. Clinical Experimental Pharmacology and Physiology, 26, 127-131.